2022 ´ëÇѽŰæÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸ ¹× Á¦6Â÷ ¼¼°è½Å°æÁ¾¾çÇÐȸ Çмú´ëȸ (1ÀÏÂ÷) : 2022-03-24±³À°ÀÏÀÚ : 2022-03-24
±³À°Àå¼Ò : ¼¿ï ÄÚ¿¢½º
±³À°ÁÖÁ¦ :
(¿Â-¿ÀÇÁº´Çà) 2022 ´ëÇѽŰæÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸ ¹× Á¦6Â÷ ¼¼°è½Å°æÁ¾¾çÇÐȸ Çмú´ëȸ (1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¾¾çÇÐȸ(ÀÎ)
´ã´çÀÚ : »ç¹«±¹
¿¬¶ôó : 02-3452-0507
À̸ÞÀÏ :
office@wfnos2022.org ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, ½Å°æ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú
Âü¼®¿¹»óÀοø : 1500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 19 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 720,000¿ø
ºñ°í WFNOSȸ¿ø±âÁØ »çÀüµî·Ï USD 500 / ÇöÀåµî·Ï USD 600
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-24 GBR 101+102, 1F 08:00~08:20 The trend of New WHO classification David Capper(Charité University Germany)
±³À°½Ã°£ 03-24 GBR 101+102, 1F 08:20~08:40 Update in New WHO Classification- Adult glioma-IDH-wildtype Arie Perry(University of California San Francisco USA)
±³À°½Ã°£ 03-24 GBR 101+102, 1F 08:40~09:00 Update in New WHO Classification - Adult glioma-IDH-mutant Ho-Keung NG(Chinese University of Hong Kong Hong Kong)
±³À°½Ã°£ 03-24 GBR 101~105 09:00~09:40 Glioma, cell of origin Luis F. Parada(Memorial Sloan Kettering Cancer Center USA)
±³À°½Ã°£ 03-24 GBR 101~105 09:40~10:20 New targets for cancer stem cells: redox regulation and differentiation Hideyuki Saya(Keio University Japan)
ÈÞ½Ä 03-24 10:20~10:40 Break ()
±³À°½Ã°£ 03-24 GBR 101+102 10:40~11:00 AI and radiomics in glioma Philipp Vollmuth(Heidelberg University Hospital Germany)
±³À°½Ã°£ 03-24 GBR 101+102 11:00~11:20 Artificial intelligence in neuro-oncology: Promising applications and challenges Sung Soo Ahn(Severance Hospital Yonsei University)
±³À°½Ã°£ 03-24 GBR 101+102 11:20~11:40 Perfusion MRI analysis for radiogenomics of gliomas: Deep-learning approach Kyu Sung Choi(Seoul National University Hospital)
±³À°½Ã°£ 03-24 GBR 103 10:40~11:00 New players in immune microenvironment for glioma management Michael Lim(Stanford University USA)
±³À°½Ã°£ 03-24 GBR 103 11:00~11:20 T cell Heterogeniety in glioma microenvironment Eui-Cheol Shin(Korea Advanced Institute of Science and Technology (KAIST))
±³À°½Ã°£ 03-24 GBR 103 11:20~11:40 Crosstalk between immune and molecuar microenvironent in gliomas Michael Platten(German Cancer Research Center (DKFZ) & Mannheim University Hospital Germany)
±³À°½Ã°£ 03-24 GBR 104+105 10:40~11:10 Ongoing Clinical Trials for Recurrent High Grade Gliomas: How Can We Make a Breakthrough? David A. Reardon(Harvard Medical School USA)
±³À°½Ã°£ 03-24 GBR 104+105 11:10~11:40 Challenges of Neuro-Oncology Clinical Trials and Future Perspectives Michael Weller(University Hospital Zurich Switzerland)
±³À°½Ã°£ 03-24 GBR 101+102 11:40~12:10 Pediatric type diffuse glioma-Low grade glioma Cynthia Hawkins(The Hospital for Sick Children Canada)
±³À°½Ã°£ 03-24 GBR 101+102 12:10~12:40 Pediatric type diffuse glioma-high grade glioma Guido Reifenberger(Heinrich-Heine-University Germany)
±³À°½Ã°£ 03-24 GBR 103 11:40~12:00 Understanding response to treatment in glioma Roel Verhaak(Jackson Laboratory for Genomic Medicine USA)
±³À°½Ã°£ 03-24 GBR 103 12:00~12:20 Evolution of gliomas: epigenetic aspect Houtan Noushmehr(Hermelin Brain Tumor Center & Henry Ford Health System USA)
±³À°½Ã°£ 03-24 GBR 103 12:20~12:40 Evolution of Glioblastoma: Proteogenomics aspects in longitudinal study Jong Bae Park(National Cancer Center)
±³À°½Ã°£ 03-24 GBR 104+105 11:40~12:00 Updates & ongoing NRG/RTOG trials for brain metastases and primary CNS tumors Minesh P Mehta(Miami Cancer Institute USA)
±³À°½Ã°£ 03-24 GBR 104+105 12:00~12:20 Updates & ongoing EORTC trials for primary brain tumors Pim J. French(Erasmus MC Cancer Institute The Netherlands)
±³À°½Ã°£ 03-24 GBR 104+105 12:20~12:40 Updates and ongoing trials of heavy ion therapy for brain tumors Jiade J. Lu(Shanghai Proton and Heavy Ion Center China)
ÈÞ½Ä 03-24 12:40~13:40 Lunch Break ()
±³À°½Ã°£ 03-24 GBR 101+102 13:40~14:00 Extent of resection threshold in malignant gliomas Nader Sanai(Barrow Neurological Institute USA)
±³À°½Ã°£ 03-24 GBR 101+102 14:00~14:20 Role of supratotal resection in gliomas Jong Hee Chang(Severance Hospital Yonsei University)
±³À°½Ã°£ 03-24 GBR 101+102 14:20~14:40 Role of surgery in Lower-grade Gliomas Lorenzo Bello(University of Milan Italy)
±³À°½Ã°£ 03-24 GBR 103 13:40~14:00 Spatial & Temporal Surgical Sampling of Glioma: Challenges & Opportunities Colin Watts(University of Birmingham UK)
±³À°½Ã°£ 03-24 GBR 103 14:00~14:20 Molecular signature of glioblastoma origin site and origin cells Seok-Gu Kang(Severance Hospital Yonsei University)
±³À°½Ã°£ 03-24 GBR 103 14:20~14:40 Resting state quiescence and lifelong neurogenesis in mouse or Possible cell of origin in other brain tumors Luis F. Parada(Memorial Sloan Kettering Cancer Center USA)
±³À°½Ã°£ 03-24 GBR 104+105 13:40~14:00 Systemic Treatment for Recurrent High Grade Gliomas: Current Standard Matthias Preusser(Medical University of Vienna Austria)
±³À°½Ã°£ 03-24 GBR 104+105 14:00~14:20 Precision Medicine and Targeted Therapy for High Grade Glioma Mark Rosenthal(Peter MacCallum Cancer Centre Australia)
±³À°½Ã°£ 03-24 GBR 104+105 14:20~14:40 Updates on Immunotherapy for High Grade Glioma Antonio Omuro(Yale Brain Tumor Center Yale University USA)
±³À°½Ã°£ 03-24 GBR 101+102 14:40~15:00 White matter anatomy of the brain Christophe Destrieux(Tours University France)
±³À°½Ã°£ 03-24 GBR 101+102 15:00~15:20 A connectomic atlas of the human cerebrum Michael E. Sughrue(Prince of Wales Private Hospital Australia)
±³À°½Ã°£ 03-24 GBR 101+102 15:20~15:40 Clinical management of gliomas at the functional regions of brain Chuanlu Jiang(Harbin Medical University China)
±³À°½Ã°£ 03-24 GBR 103 14:40~15:00 Tumor microtubes: drivers of glioma progression and resistance Frank Winkler(Heidelberg University and German Cancer Research Center Germany)
±³À°½Ã°£ 03-24 GBR 103 15:00~15:20 Electrical and synaptic integration of glioma into neural circuit Michelle Monje(Stanford University USA)
±³À°½Ã°£ 03-24 GBR 103 15:20~15:40 Cellular quiescence and resistance in Glioblastoma Lachlan Harris(The Francis Crick Institute UK)
±³À°½Ã°£ 03-24 GBR 104+105 14:40~15:00 Management of Side Effects of Cytotoxic Chemotherapy in Brain Tumor Joo Han Lim(Inha University)
±³À°½Ã°£ 03-24 GBR 104+105 15:00~15:20 Adverse Events of Antiangiogenic Agents and Other Targeted Agents Wolfgang Wick(University of Heidelberg Germany)
±³À°½Ã°£ 03-24 GBR 104+105 15:20~15:40 Immune Related Adverse Events John F de Groot(University of California San Francisco USA)
±³À°½Ã°£ 03-24 GBR 101+102 15:50~16:10 Virtual Reality for Neurosurgery Walter Jean(Lehigh Valley Health Network USA)
ÈÞ½Ä 03-24 15:40~16:00 Break ()
±³À°½Ã°£ 03-24 GBR 101+102 16:10~16:30 Smart Cyber Operating Theater for brain tumor surgery Yoshihiro Muragaki(Tokyo Women)
±³À°½Ã°£ 03-24 GBR 101+102 16:30~16:50 High-field Intraoperative MRI and Glioma Surgery Michael R Chicoine(Washington University School of Medicine USA)
±³À°½Ã°£ 03-24 GBR 103 16:00~16:30 Elucidating the resistance to immunotherapy in brain tumors using a humanized microbiome mouse model Braden C. McFarland(University of Alabama at Birmingham USA)
±³À°½Ã°£ 03-24 GBR 103 16:30~17:00 Gut microbiota alterations affect glioma growth and innate immune cells involved in tumor immunosurveillance in mice Cristina Limatola(Sapienza University Italy)
±³À°½Ã°£ 03-24 GBR 104+105 16:00~16:20 Why should we assess quality of life in adult brain tumor patients? Zarnie Lwin(University of Queensland Australia)
±³À°½Ã°£ 03-24 GBR 104+105 16:20~16:40 Fear of cancer recurrence in adult CNS patients Phyllis Butow(The University of Sydney Australia)
±³À°½Ã°£ 03-24 GBR 104+105 16:40~17:00 Later and long-term effect of pediatric brain tumor treatment Jung Lee(Seoul National University)
±³À°½Ã°£ 03-24 GBR 101+102 17:00~17:20 Cranial nerve preservation in the endoscopic skull base surgery Won Kim(University of California Los Angeles USA)
±³À°½Ã°£ 03-24 GBR 101+102 17:20~17:40 How to manage the complication of endoscopic skull base surgery Masahiro Shin(University of Tokyo Japan)
±³À°½Ã°£ 03-24 GBR 101+102 17:40~18:00 Optical Principles of Fluorescence-Guidedendoscopic tumor surgery John Lee(University of Pennsylvania USA)
±³À°½Ã°£ 03-24 GBR 103 17:00~17:20 Identification and clinical implications of MET alterations in brain tumor Tao Jiang(Capital Medical University China)
±³À°½Ã°£ 03-24 GBR 103 17:20~17:40 RNA interference in glioma biology Adelheid Woehrer(Institute of Neurology Medical University of Vienna Austria)
±³À°½Ã°£ 03-24 GBR 103 17:40~18:00 Glioma epigenetics: glioma and histone remodeling MinGyu Lee(MD Anderson Cancer Center USA)